middle.news
Why Did Mayne Pharma Pull Its NEXTSTELLIS® Presentation After FDA Warning?
2:33am on Monday 2nd of June, 2025 AEST
•
Pharmaceuticals
Read Story
Why Did Mayne Pharma Pull Its NEXTSTELLIS® Presentation After FDA Warning?
2:33am on Monday 2nd of June, 2025 AEST
Key Points
FDA issued Untitled Letter over promotional claims for NEXTSTELLIS®
Mayne Pharma voluntarily withdrew the referenced speaker presentation
Sales and distribution of NEXTSTELLIS® in the US remain unaffected
Company to respond to FDA within required timeframe
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
MAYNE PHARMA (ASX:MYX)
OPEN ARTICLE